Trial · NCT01426438
Outcomes14
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 14 of 14
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Absolute Change in Relative FMD (%) | 0 and 24 weeks | This is an as-treated analysis limited to 74 participants who had 24 weeks of follow up and a useable week 24 scan. | % FMD | MEDIAN |
| SECONDARY | Change in Cholesterol | 0 and 24 weeks | This is an as-treated analysis limited to 74 participants who had 24 weeks of follow up and a useable week 24 scan and had lipid panels at weeks 0 and 24. | mg/dL | MEDIAN |
| SECONDARY | Change in Triglycerides | 0 and 24 weeks | This is an as-treated analysis limited to 74 participants who had 24 weeks of follow up and a useable week 24 scan. | mg/dL | MEDIAN |
| SECONDARY | Men: Change in HDL Cholesterol | 0 and 24 weeks | Men in the as-treated analysis population, limited to 74 participants who had 24 weeks of follow up and a useable week 24 scan. | mg/dL | MEDIAN |
| SECONDARY | Women: Change in HDL Cholesterol | 0 and 24 weeks | Women in the as-treated analysis population, limited to 74 participants who had 24 weeks of follow up and a useable week 24 scan. | mg/dL | MEDIAN |
| SECONDARY | Change in HDL Particles | 0 and 24 weeks | This is an as-treated analysis limited to 74 participants who had 24 weeks of follow up and a useable week 24 scan. | nmol/L | MEDIAN |
| SECONDARY | Change in Non-HDL Cholesterol | 0 and 24 weeks | This is an as-treated analysis limited to 74 participants who had 24 weeks of follow up and a useable week 24 scan. | mg/dL | MEDIAN |
| SECONDARY | Change in LDL Cholesterol | 0 and 24 weeks | This is an as-treated analysis limited to 74 participants who had 24 weeks of follow up and a useable week 24 scan. | mg/dL | MEDIAN |
| SECONDARY | Change in Small LDL Particles | 0 and 24 weeks | This is an as-treated analysis limited to 74 participants who had 24 weeks of follow up and a useable week 24 scan. | nmol/L | MEDIAN |
| SECONDARY | Change in Large HDL Particles | 0 and 24 weeks | This is an as-treated analysis limited to 74 participants who had 24 weeks of follow up and a useable week 24 scan. | nmol/L | MEDIAN |
| SECONDARY | Change in HOMA-IR | 0 and 24 weeks | This is an as-treated analysis limited to 74 participants who had 24 weeks of follow up and a useable week 24 scan. | HOMA IR Score | MEDIAN |
| SECONDARY | Change in IL-6 | 0 and 24 weeks | This is an as-treated analysis limited to 74 participants who had 24 weeks of follow up and a useable week 24 scan. | pg/ml | MEDIAN |
| SECONDARY | Change in C-reactive Protein (CRP) | 0 and 24 weeks | This is an as-treated analysis limited to 74 participants who had 24 weeks of follow up and a useable week 24 scan. | ug/ml | MEDIAN |
| SECONDARY | Change in D-Dimer | 0 and 24 weeks | This is an as-treated analysis limited to 74 participants who had 24 weeks of follow up and a useable week 24 scan. | ug/ml | MEDIAN |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01426438/outcomes